Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
45 hedge funds and large institutions have $9.8M invested in Enzo Biochem, Inc. in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 7 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
5% more funds holding
Funds holding: 43 → 45 (+2)
31% less capital invested
Capital invested by funds: $14.2M → $9.8M (-$4.37M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$73K |
| 2 |
EGM
Engineers Gate Manager
New York
|
+$54.2K |
| 3 |
VF
Virtu Financial
New York
|
+$50.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$35.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$20.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$166K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$22K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$19.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.3K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$15.1K |
ENZ Hedge Fund Activity: Q4 2024 in Review
45 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2024, worth a combined $9.8M — down 31% from $14.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ENZ positions and 7 closed out — a net gain of 3 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was Wittenberg Investment Management, adding an estimated $73K. The largest seller was Renaissance Technologies, cutting an estimated $166K.
- 45 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2024, up from 43 in Q3 2024.
- Funds reported $9.8M of Enzo Biochem, Inc. stock for Q4 2024, down 31% quarter-over-quarter.
- 10 funds opened new Enzo Biochem, Inc. positions in Q4 2024 and 7 closed out, a net change of +3 holders.
- The largest Enzo Biochem, Inc. buyer in Q4 2024 was Wittenberg Investment Management, an estimated $73K added.
- The largest Enzo Biochem, Inc. seller in Q4 2024 was Renaissance Technologies, an estimated $166K sold.
Based on aggregated 13F filings for Q4 2024.